Portrait of Eiko with a blue gradient and hash pattern overlay

Advancing the Way Heart Failure is Treated

More than 170,000 patients have been supported with Impella® heart pumps

Heart Recovery is Possible With Impella

In a randomized controlled trial, 8-in-10 patients treated with Impella heart pumps experienced reduction in heart failure symptoms or improvement in heart function.2,8 Their native heart function recovered, and heart failure symptoms diminished, such as fatigue, shortness of breath, swelling, and coughing,1,2 in just 90 days after a Protected PCI procedure as compared to other forms of treatment.2 

Start Here

Reduction in Death, Heart Attack and Stroke

in 90-day post-hospitalization as compared to other support methods1

Fewer Repeat Visits

to the hospital for heart-related issues other than traditional therapy3

Fewer Days in the Hospital

after procedure compared to traditional therapy3, 4, 5, 6, 7

Impella is the only U.S. FDA-approved percutaneous heart pump technology indicated for patients with severe coronary artery disease requiring high-risk PCI

Patients Share Their Stories of Heart Recovery

 

"I really feel 10 years younger!"

Mattie Warren, 77

 

"Following the procedure, I proudly climbed to the top of the bleachers."

Jim Hoag, 73

 

"I have never felt better!"

Mary Hanel, 83

Find a Hospital

Enter your zip code to find a hospital near you that offers Protected PCI with Impella.

References

  1. Dangas, G.D., et al. (2014). Am J Cardiol, 113(2), 222-228. 
  2. O’Neill, W.W., et al. (2012). Circulation, 126(14), 1717-1727.
  3. Gregory, D., et al. (2013). Am Health Drug Benefits, 6(2), 88-99.
  4. Maini, B., et al. (2014). Catheter Cardiovasc Interv, 83(6), E183-E192. 
  5. Gregory, D., et al. (2013). J Manag Care Med, 16(1), 61-69.  
  6. O’Neill, W.W., et al. (2014). J Interviev Cardiol, 27(1), 1-11.
  7. Roos, J.B., et al. (2013). J Med Econ, 16(3), 3381-390.
  8. PROTECT II Data on File

NPS-1760